Business NewsNews

ACCESS VASCULAR HYDROPICC CATH RAISES $4 MILLION

 

 

Medical device developer Access Vascular has raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk.

The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis.

AngelMD Access Vascular syndicate co-lead Arun Jagannathan, MD, said the firm was impressed with the expertise and dedication of the team, as well as Access Vascular’s novel approach to addressing a critical unmet need in venous access.

“By leveraging its bulk hydrophilic biomaterial, Access Vascular’s devices have the potential to eliminate thrombosis and the cascade of complications that arise with the currently available devices,” Dr. Jagannathan said. VTN

READ MORE:  Access Vascular

 

Previous post

TERASON EXHIBITS 3300 NEXGEN US AT IVC

Next post

HOLOGIC UNVEILS NEW FLUOROSCOPY SYSTEM

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.